Literature DB >> 12121669

Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis.

Sergei Chuvpilo1, Eriks Jankevics, Dimitri Tyrsin, Askar Akimzhanov, Denis Moroz, Mithilesh Kumar Jha, Jan Schulze-Luehrmann, Brigitte Santner-Nanan, Elizaveta Feoktistova, Thomas König, Andris Avots, Edgar Schmitt, Friederike Berberich-Siebelt, Anneliese Schimpl, Edgar Serfling.   

Abstract

Threshold levels of individual NFAT factors appear to be critical for apoptosis induction in effector T cells. In these cells, the short isoform A of NFATc1 is induced to high levels due to the autoregulation of the NFATc1 promoter P1 by NFATs. P1 is located within a CpG island in front of exon 1, represents a DNase I hypersensitive chromatin site, and harbors several sites for binding of inducible transcription factors, including a tandemly arranged NFAT site. A second promoter, P2, before exon 2, is not controlled by NFATs and directs synthesis of the longer NFATc1/B+C isoforms. Contrary to other NFATs, NFATc1/A is unable to promote apoptosis, suggesting that NFATc1/A enhances effector functions without promoting apoptosis of effector T cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121669     DOI: 10.1016/s1074-7613(02)00329-1

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  80 in total

Review 1.  Calcineurin: a central controller of signalling in eukaryotes.

Authors:  José Aramburu; Joseph Heitman; Gerald R Crabtree
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

Review 2.  NFAT, immunity and cancer: a transcription factor comes of age.

Authors:  Martin R Müller; Anjana Rao
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

3.  NFAT1 transcription factor regulates cell cycle progression and cyclin E expression in B lymphocytes.

Authors:  Leonardo K Teixeira; Nina Carrossini; Cristiane Sécca; José E Kroll; Déborah C DaCunha; Douglas V Faget; Lilian D S Carvalho; Sandro J de Souza; João P B Viola
Journal:  Cell Cycle       Date:  2016-07-11       Impact factor: 4.534

4.  Early growth response-1 is required for CD154 transcription.

Authors:  Randy Q Cron; Rupa Bandyopadhyay; Anna Genin; Michael Brunner; Gilbert J Kersh; Jiyi Yin; Terri H Finkel; Mary K Crow
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

5.  T-bet antagonizes mSin3a recruitment and transactivates a fully methylated IFN-gamma promoter via a conserved T-box half-site.

Authors:  Yingkai Tong; Thomas Aune; Mark Boothby
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

6.  Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway.

Authors:  Malte Buchholz; Alexandra Schatz; Martin Wagner; Patrick Michl; Thomas Linhart; Guido Adler; Thomas M Gress; Volker Ellenrieder
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

7.  Accumulation of NFAT mediates IL-2 expression in memory, but not naïve, CD4+ T cells.

Authors:  Oliver Dienz; Sheri M Eaton; Troy J Krahl; Sean Diehl; Colette Charland; John Dodge; Susan L Swain; Ralph C Budd; Laura Haynes; Mercedes Rincon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

8.  Sumoylation of the transcription factor NFATc1 leads to its subnuclear relocalization and interleukin-2 repression by histone deacetylase.

Authors:  Arnab Nayak; Judith Glöckner-Pagel; Martin Vaeth; Julia E Schumann; Mathias Buttmann; Tobias Bopp; Edgar Schmitt; Edgar Serfling; Friederike Berberich-Siebelt
Journal:  J Biol Chem       Date:  2009-02-14       Impact factor: 5.157

9.  Doxorubicin-mediated apoptosis in glioma cells requires NFAT3.

Authors:  Sreelatha Gopinath; Sravan K Vanamala; Meena Gujrati; Jeffrey D Klopfenstein; Dzung H Dinh; Jasti S Rao
Journal:  Cell Mol Life Sci       Date:  2009-09-27       Impact factor: 9.261

10.  Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor signaling.

Authors:  Askar Akimzhanov; Laszlo Krenacs; Timm Schlegel; Stefan Klein-Hessling; Enikö Bagdi; Eva Stelkovics; Eisaku Kondo; Sergei Chuvpilo; Philipp Wilke; Andris Avots; Stefan Gattenlöhner; Hans-Konrad Müller-Hermelink; Alois Palmetshofer; Edgar Serfling
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.